Hostname: page-component-7479d7b7d-t6hkb Total loading time: 0 Render date: 2024-07-14T10:35:42.779Z Has data issue: false hasContentIssue false
  • English
  • Français

Nutrient-induced secretion and metabolic effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1

Published online by Cambridge University Press:  11 October 2007

J. M. E. Knapper ,
L. M. Morgan  and
J. M. Fletcher
J. M. E. Knapper
Affiliation:
Nutrition Research Group, School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH
L. M. Morgan
Affiliation:
Nutrition Research Group, School of Biological Sciences, University of Surrey, Guildford, Surrey GU2 5XH
J. M. Fletcher
Affiliation:
Unilever Research, Colworth House, Sharnbrook, Bedford MK44 1LQ
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Regulation of Gastrointestinal Secretion
Information
Proceedings of the Nutrition Society , Volume 55 , Issue 1B , March 1996 , pp. 291 - 305
Copyright
Copyright © The Nutrition Society 1996

References

Anderson, D. K., Ehali, D., Brown, J. C., Tobin, J. D. & Andres, R. (1978). Oral glucose augmentation of insulin secretion. Journal of Clinical Investigation 62, 152–161.CrossRefGoogle Scholar
Bailey, C. J., Flatt, P. R., Kwasowski, P., Powell, C. J. & Marks, V. (1986). Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob/ob) mice fed high fat and high carbohydrate cafeteria diets. Acta Endocrinologica 112, 224–229.Google Scholar
Beety, J. M., Ranganath, L., Morgan, L. M., Howland, R., Wright, J. & Marks, V. (1994). Attenuation of plasma GLP-1 responses to oral carbohydrate but not oral fat in obese subjects. Digestive Diseases and Sciences 39, 1809.Google Scholar
Bell, G. I., Santerre, R. F. & Mullenbach, G. I. (1983). Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302, 716–718.CrossRefGoogle ScholarPubMed
Bloom, S. R. & Polak, J. M. 1981 Gut Hormones, 2nd ed. 3–18Edinburgh: Churchill Livingstone.Google Scholar
Brown, J. C., Dryburgh, J. R., Ross, S. A. & Dupré, J. (1975). Identification and actions of gastric inhibitory polypeptide. Recent Progress in Hormone Research 31, 487–532.Google ScholarPubMed
Brunzell, J. D., Miller, N. E., Alaupovic, P., St Hilaire, R. J., Wang, C. S., Sarson, D. L., Bloom, S. R. & Lewis, B. (1983). Familial chylomicronaemia due to a circulating inhibitor of lipoprotein lipase activity. Journal of Lipid Research 24, 12–19.CrossRefGoogle Scholar
Cleator, I. G. M. & Gourley, R. H. (1975). Release of immunoreactive gastric inhibitory polypeptide (IRGIP) by oral ingestion of food substances. American Journal of Surgery 13, 128–135.CrossRefGoogle Scholar
Conlon, J. M. (1988). Proglucagon-derived peptides: nomenclature, biosynthetic relationships and physiological roles. Diabetologia 31, 563–566.CrossRefGoogle ScholarPubMed
Creutzfeldt, W. & Ebert, R. (1985). New developments in the incretin concept. Diabetologia 28, 565–573.CrossRefGoogle ScholarPubMed
Creutzfeldt, W., Ebert, R., Williams, B., Frerichs, H. & Brown, J. C. (1978). GIP and insulin in obesity: increased response to stimulation and detective feedback control of serum levels. Diabetologia 14, 15–24.CrossRefGoogle Scholar
Drucker, D. J., Phillippe, J., Mojsov, S., Chick, W. L. & Habener, J. F. (1987). Glucagon-ike peptide 1 stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proceedings of the National Academy of Sciences, USA 84, 3434–3438.CrossRefGoogle Scholar
Dupré, J., Greenidge, N., McDonald, T. J., Ross, S. A. & Rubinstein, D. (1976). Inhibition of action of glucagon and adipocytes by gastric inhibitory polypeptide. Metabolism 25, 1197–1199.CrossRefGoogle ScholarPubMed
Ebert, R. & Creutzfeldt, W. (1987). Metabolic effects of gastric inhibitory polypeptide. Frontiers in Hormone Research 16, 175–185.CrossRefGoogle Scholar
Ebert, R., Nauck, N. & Creutzfeldt, W. (1991). Effect of exogenous and endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. Hormone and Metabolic Research 23, 1197–1199.CrossRefGoogle ScholarPubMed
Eckel, R. H., Fujimoto, W. Y. & Brunzell, J. D. (1979). Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28, 1141–1142.CrossRefGoogle ScholarPubMed
Elahi, D., McAloon-Dyke, M., Fukagawa, N. K., Meneilly, G. S., Sclater, A. L., Minaker, K. L., Habener, J. F. & Andersen, D. K. (1994). The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-Iike peptide-1 (7–37) in normal and diabetic subjects. Regulatory Peptides 51, 63–74.CrossRefGoogle ScholarPubMed
Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J. & Marks, V. (1993). Glucagon-like peptide-1 (7–36) amide and glucose dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. Journal of Endocrinology 138, 159–166.CrossRefGoogle ScholarPubMed
Ellis, P. R., Roberts, F. G., Low, A. G. & Morgan, L. M. (1995). The effect of high-molecular-weight guar gum on net apparent glucose absorption and net apparent insulin and gastric inhibitory polypeptide production in the growing pig: relationship to rheological changes in jejunal digesta. British Journal of Nutrition 74, 539–556.CrossRefGoogle ScholarPubMed
Falko, J. M., Crockett, S. E., Cataland, S. & Massaferri, E. L. (1975). Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man. Journal of Endocrinology and Metabolism 41, 260–265.CrossRefGoogle ScholarPubMed
Fehmann, H.-C, Göke, B., Göke, R., Trautmann, M. E. & Arnold, R. (1990). Synergistic stimulatory effect of glucagon-like peptide-1(7–36)amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas. FEBS Letters 252, 109–112.CrossRefGoogle Scholar
Fielding, B. A., Owen, R., Callow, J. & Frayn, K. N. (1995). Origin of the early postprandial triacylglycerol peak. Proceedings of the Nutrition Society 54, 53 A.Google Scholar
Flatt, P. R., Bailey, C. J., Kwasowski, P., Swanston-Flatt, S. K. & Marks, V. (1983). Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice. Diabetes 32, 433–35.CrossRefGoogle ScholarPubMed
Flatt, P. R., Kwasowski, P., Howland, R. J. & Bailey, C. J. (1991). Gastric inhibitory polypeptide and insulin responses to orally administered amino acids in genetically obese hyperglycaemic (ob/ob) mice. Journal of Nutrition 121, 1123–1128.CrossRefGoogle Scholar
Fukase, N., Igarashi, M., Takahashi, H., Manaka, H., Yamatani, K., Daimon, M., Tominaga, M. & Sasaki, H. (1993). Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabetic Medicine 10, 44–49.CrossRefGoogle ScholarPubMed
Fukase, N., Takahashi, H., Manaka, H., Igarashi, M., Yamatani, K., Daimon, M., Sugiyama, K., Tominaga, M. & Sasaki, H. (1992). Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion. Diabetes Research in Clinical Practice 15, 187–195.CrossRefGoogle ScholarPubMed
Göke, R., Cole, T. & Conlon, J. M. (1989). Characterisation of the receptor for glucagon-like peptide-1(7–36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking. Journal of Molecular Endocrinology 2, 93–98.CrossRefGoogle ScholarPubMed
Göke, R. & Conlon, J. M. (1988). Receptors for glucagon-like peptide-1(7–36)amide on rat insulinoma-derived cells. Journal of Endocrinology 116, 357–362.CrossRefGoogle ScholarPubMed
Goldstein, J. L., Ho, Y. K., Brown, M. S., Innerarity, T. L. & Mahley, R. W. (1980). Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine B-very low density lipoproteins. Journal of Biological Chemistry 255, 1839–1848.CrossRefGoogle Scholar
Groot, P. H. E., van Stiphout, W. A. H. J., Krauss, X. H., Jensen, J., van Tol, A., van Ramshorst, E., Chin-On, S., Hofman, A., Cresswell, S. R. & Hanekes, L. (1991). Postprandial lipoprotein metabolism in normolipidaemic men with and without coronary artery disease. Atherosclerosis and Thrombosis 11, 653–662.Google Scholar
Hampton, S. M., Kwasowksi, P., Tan, K., Morgan, L. M. & Marks, V. (1983). Effect of pretreatment with a high fat diet on gastric inhibitory polypeptide and insulin responses to oral triolein and glucose in rats. Diabetologia 24, 278–281.CrossRefGoogle ScholarPubMed
Holst, J. J. (1994). Glucagonlike peptide 1: A newly discovered gastrointestinal hormone. Gastroenterology 107, 1848–1855.CrossRefGoogle ScholarPubMed
Jones, I. R., Obens, D. R., Luzio, S. & Hayes, T. M. (1989). Obesity is associated with increased post-prandial GIP levels which are not reduced by dietary restriction and weight loss. Diabete et Métabolisme 15, 11–22.Google Scholar
Jorde, R., Burhol, P. G. & Schultz, T. B. (1983). Fasting and postprandial plasma GIP values in man measured with seven different antisera. Regulatory Peptides 7, 83–94.CrossRefGoogle ScholarPubMed
Jörnvall, H., Carlquist, M., Kwauk, S., Otte, S. C., McIntosh, C. H. S., Brown, J. C. & Mutt, V. (1981). Amino acid sequence and heterogeneity of gastric inhibitory polypeptide (GIP). FEBS Letters 123, 205–210.CrossRefGoogle ScholarPubMed
Karpe, F., Tornvall, P., Olivecrona, T., Steiner, G., Carlson, L. A. & Hamsten, A. (1993). Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis 98, 33–49.CrossRefGoogle ScholarPubMed
Kervran, A., Randon, J. & Girard, J. R. (1987). Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat. Endocrinology 121, 704–713.CrossRefGoogle ScholarPubMed
Knapper, J. M. E., Bailey, C. J. & Flatt, P. R. (1992). Glucagon-like peptide-1(7–36)amide and glucose-dependent insulinotropic polypeptide in the hyperinsulinaemia of obese hyperglycaemic (ob/ob) mice. Proceedings of the Nutrition Society 52, 38 A.Google Scholar
Knapper, J. M. E., Furlonger, N., Zampelas, A., Jackson, K., Morgan, L., Kafatos, A., Kapsokephalou, M. & Williams, C. M. (1995 a). Postprandial triacylglycerol, GIP and insulin responses to a mixed meal in UK and Greek subjects. 2nd International Congress of the International Society for the Study of Fatty Acids and Lipids p. A47, BethesdaMaryland.Google Scholar
Knapper, J. M. E., Heath, A., Fletcher, J. M., Morgan, L. M. & Marks, V. (1995 b). GIP and GLP-1(7–56)amide secretion in response to intraduodenal infusions in pigs. Comparative Biochemistry and Physiology 111C, 445–450.Google Scholar
Knapper, J. M. E., Morgan, L. M., Fletcher, J. M. & Marks, V. (1995 c). Plasma and intestinal concentrations of GIP and GLP-1(7–36)amide during suckling and after weaning in pigs. Hormone and Metabolic Research 27, 485–490.CrossRefGoogle ScholarPubMed
Knapper, J. M. E., Puddicombe, S. M., Morgan, L. M., Fletcher, J. M. & Marks, V. (1995 d). Investigations into the actions of glucose dependent insulinotropic polypeptide and glucagon-like peptide-1(7–36)amide on lipoprotein lipase activity in explants of rat adipose tissue. Journal of Nutrition 125, 183–188.Google ScholarPubMed
Kreymann, B., Williams, G., Ghatei, M. A. & Bloom, S. R. (1987). Glucagon-like peptide-17–36: A physiological incretin in man. Lancet ii, 1300–1304.CrossRefGoogle Scholar
Kreymann, B., Yiangou, Y., Kanse, S., Williams, G., Ghatei, M. A. & Bloom, S. R. (1988). Isolation and characterisation of GLP-17–36amide from rat intestine. FEBS Letters 242, 167–170.CrossRefGoogle Scholar
Kwasowski, P., Flatt, P. R., Bailey, C. J. & Marks, V. (1985). Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob/ob) mice. Bioscience Reports 5, 701–705.CrossRefGoogle ScholarPubMed
Lardinois, C. K., Starich, G. H. & Mazzaferri, E. L. (1988). The postprandial response of gastric inhibitory polypeptide to various dietary fats in man. Journal of the American College of Nutrition 7, 241–247.CrossRefGoogle ScholarPubMed
Low, A. G. (1990). Nutritional regulation of gastric secretion, digestion and emptying. Nutrition Research Reviews 3, 229–252.CrossRefGoogle ScholarPubMed
Mentlein, R., Gallwitz, B. & Schmidt, W. E. (1993). Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7–36)amide, peptide histidine methionine and is responsible for their degradation in human serum. European Journal of Biochemistry 214, 829–835.CrossRefGoogle ScholarPubMed
Merida, E., Delgado, E., Molina, L. M., Villanueva-Penacarillo, M. L. & Valverde, I. (1993). Presence of glucagon and glucagon-like peptide-1(7–36)amide receptors in solubilised membranes of human adipose tissue. Journal of Clinical Endocrinology and Metabolism 77, 1654–1657.Google ScholarPubMed
Miholic, J., Ørskov, C., Holst, J. J., Kotzer, J. & Meyer, H. J. (1991). Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1) and reactive hypoglycaemia after total gastrectomy. Digestive Diseases and Sciences 36, 1361–1370.CrossRefGoogle ScholarPubMed
Montrose-Rafizadeh, C., Egan, J. M. & Roth, J. (1994). Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046–38 cells: mechanisms of action. Endocrinology 135, 589–594.CrossRefGoogle ScholarPubMed
Moody, A. J., Thim, L. & Valverde, I. (1984). The isolation and sequencing of human gastric inhibitory polypeptide (GIP). FEBS Letters 172, 142–148.CrossRefGoogle Scholar
Moore, B., Edie, E. S. & Abram, J. H. (1906). On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochemical Journal 1, 28–38.CrossRefGoogle Scholar
Morgan, L. M. (1992). Insulin secretion and the enteroinsular axis. In Nutrient Regulation of Insulin Secretion, pp. 1–22 [Flatt, P. R., editor]. London: The Biochemical Society.Google Scholar
Morgan, L. M., Hampton, S. M., Tredger, J. A., Cramb, R. & Marks, V. (1988). Modification of gastric inhibitory polypeptide (GIP) secretion in man by a high-fat diet. British Journal of Nutrition 59, 373–380.CrossRefGoogle Scholar
Morgan, L. M., Tredger, J. A., Hampton, S. M., Kwasowski, P., Wright, J., Dunn, M. & Marks, V. (1983). Effect of diet upon response to oral fat and glucose in man; modification in control of the enteroinsular axis. Scandinavian Journal of Gastroenterology 18, 99–101.Google Scholar
Murphy, M. C., Isherwood, S. G., Sethi, S., Gould, B. J., Wright, J. W., Knapper, J. M. & Williams, C. M. (1995). Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase?. European Journal of Clinical Nutrition 49, 579–588.Google ScholarPubMed
Murphy, M. C., Zampelas, A., Puddicombe, S. M., Furlonger, N. P., Morgan, L. M. & Williams, C. M. (1993). Pre-translational regulation of the expression of the lipoprotein lipase gene by dietary fatty acids in the rat. British Journal of Nutrition 70, 727–726.CrossRefGoogle Scholar
Nauck, M. A., Bartels, E., Ørskov, C., Ebert, R. & Creutzfeldt, W. (1993 a). Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1 (7–36) amide infused at near-physiological insulinotropic and glucose concentrations. Journal of Clinical Endocrinology and Metabolism 76, 912–917.Google ScholarPubMed
Nauck, M. A., Kleine, N., Ørskov, C., Hoist, J. J., Willms, B. & Cyeutzfeldt, W. (1993 b). Normalisation of fasting hyperglycaemia by exogenous GLP-l(7–36)amide in type 2-diabetic patients. Diabetologia 36, 741–744.CrossRefGoogle Scholar
Oben, J., Morgan, L., Fletcher, J., Flatt, P., Knapper, J. M. & Marks, V. (1992). The role of insulin and GIP in lipid metabolism in obese (ob/ob) mice. Proceedings of the Nutrition Society 51, 188A.Google Scholar
Oben, J., Morgan, L. M., Fletcher, J. & Marks, V. (1991). Effect of enteropancreatic hormones, gastric inhibitory polypeptide and glucagon-like peptide-1(7–36)amide on fatty acid synthesis in explants of rat adipose tissue. Journal of Endocrinology 130, 267–272.CrossRefGoogle ScholarPubMed
Ørskov, C., Hoist, J. J., Knuhtsen, S., Baldissera, F. G. A., Poulsen, S. S. & Vagn Nielsen, O. (1986). Glucagon-like peptides GLP-1 & GLP-2, predicted products of the glucagon gene are secreted separately from pig small intestine but not pancreas. Endocrinology 119, 1467–1475.CrossRefGoogle Scholar
Ørskov, C. & Poulssen, S. S. (1991). Glucagonlike peptide-1(7–36)-amide receptors only in islets of Langerhans. Diabetes 40, 1292–1296.CrossRefGoogle ScholarPubMed
Penman, E., Wass, J. A. H., Medback, S., Morgan, L. M., Lewis, J., Besser, G. M. & Rees, L. H. (1981). Response of circulating somatostatin to nutritional stimuli in normal subjects. Gastroenterology 81, 692–699.CrossRefGoogle ScholarPubMed
Ponter, A. A., Salter, D. N., Morgan, L. M. & Flatt, P. R. (1991). The effect of energy source and feeding level on the hormones of the entero–insular axis and plasma glucose in the growing pig. British Journal of Nutrition 66, 187–197.CrossRefGoogle ScholarPubMed
Roberge, J. N. & Brubaker, P. L. (1993). Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133, 233–240.CrossRefGoogle Scholar
Schmidt, W. E., Siegel, E. G. & Creutzfeldt, W. (1985). Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28, 704–707.CrossRefGoogle Scholar
Service, P. J., Rizza, R. A., Westland, R. E., Hall, L. D., Gerich, J. E. & Go, V. L. W. (1984). Gastric inhibitory polypeptide in obesity and diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 58, 1133–1140.CrossRefGoogle ScholarPubMed
Shima, K., Suda, T., Nishimoto, K. & Yoshimoto, S. (1990). Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 from canine ileal loops. Acta Endocrinologica (Copenhagen) 123, 464–470.Google ScholarPubMed
Solcia, E., Usellini, L., Buffa, R., Rindi, G., Villani, L., Aguzzi, A. & Silini, E. (1989). Endocrine cells producing regulatory peptides. In Experimentia Supplement no. 56, Regulatory Peptides, pp. 220–246 [Polak, J. M., editor]. Berlin: Birkhäuser Verlag.CrossRefGoogle Scholar
Sykes, S., Morgan, L. M., English, J. & Marks, V. (1980). Evidence for preferential stimulation of gastric inhibitory polypeptide secretion in the rat by actively transported carbohydrates and their analogues. Journal of Endocrinology 85, 201–207.CrossRefGoogle ScholarPubMed
Szecowka, J., Grill, V., Sandberg, E. & Efendic, S. (1982). Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat. Acta Endocrinologica 99, 416–421.Google ScholarPubMed
Thomas, F. B., Shook, D. F., O'Dorisio, T. M., Cataland, S., Mekhjian, H. S., Caldwell, J. H. & Mazzaferri, E. L. (1977). Localisation of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Gastroenterology 72, 49–54.CrossRefGoogle ScholarPubMed
Thomas, F. B., Sinar, D., Mazzaferri, E. L., Cataland, S., Mekhjian, H. S., Caldwell, J. H. & Fromkes, J. J. (1978). Selective release of gastric inhibitory polypeptide by intraduodenal amino acid perfusion in man. Gastroenterology 74, 1261–1265.CrossRefGoogle ScholarPubMed
Thomson, A. B. R. & Dietschy, J. M. (1981). Intestinal lipid absorption: major extracellular and intracellular events. In Physiology of the Gastrointestinal Tract, vol. 2, 1147–1220 [Johnson, L. R., editor]. New York: Raven Press.Google Scholar
Unger, R. H. & Eisentraut, A. M. (1969). Entero–insular axis. Archives of International Medicine 123, 261–266.CrossRefGoogle ScholarPubMed
Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J. & Bonner, T. I. (1993). Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133, 2861–2870.CrossRefGoogle ScholarPubMed
Valverde, I., Merida, E., Delgado, E., Trapote, M. A., Villanueva-Penacarillo, M. L. (1993). Presence and characterisation of glucagon-like peptide-1(7–36)amide receptors in solubilised membranes of rat adipose tissue. Endocrinology 132, 75–79.CrossRefGoogle ScholarPubMed
Varndell, I. M., Bishop, A. E., Sikri, K. L., Uttenthal, L. O., Bloom, S. R. & Polak, J. M. (1985). Localisation of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. Journal of Histochemistry and Cytochemistry 44, 1080–1086.CrossRefGoogle Scholar
Wasada, T., McCorkle, K., Harris, V., Kawai, K., Howard, B. & Unger, R. H. (1981). Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs. Journal of Clinical Investigation 68, 1106–1107.CrossRefGoogle ScholarPubMed
Willms, B., Ebert, R. & Creutzfeldt, W. (1978). Gastric inhibitory polypeptide (GIP) and insulin in obesity II. Reversal of increased response to stimulation by starvation or food restriction. Diabetologia 14, 379–387.CrossRefGoogle ScholarPubMed